A randomized, placebo-controlled, double-blind study of the use of dutasteride for improving peri-operative and long-term outcomes of photoselective vaporization of the prostate (DOP study).
Latest Information Update: 15 Jul 2023
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms DOP
- 01 Nov 2009 Results have been published in the Journal of Urology.
- 01 Nov 2009 Status changed from active, no longer recruiting to completed according to results published in the Journal of Urology.
- 18 Nov 2006 New trial record.